Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
52.20
-4.50 (-7.94%)
At close: Aug 6, 2026, 4:00 PM EDT
52.30
+0.10 (0.19%)
Pre-market: Aug 7, 2026, 7:13 AM EDT
Exelixis Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 281.45 | 482.49 | 217.37 | 262.99 | 501.2 | 647.17 |
Short-Term Investments | 557.94 | 576.6 | 893.9 | 732.31 | 807.27 | 819.91 |
Cash & Short-Term Investments | 839.39 | 1,059 | 1,111 | 995.3 | 1,308 | 1,467 |
Cash Growth | 6.10% | -4.70% | 11.65% | -23.93% | -10.81% | 21.59% |
Accounts Receivable | 322.21 | 286.92 | 265.44 | 237.41 | 214.78 | 282.65 |
Inventory | 28.73 | 21.69 | 22.39 | 17.32 | 33.3 | 27.49 |
Other Current Assets | 60.5 | 75.6 | 68.48 | 67.93 | 62.21 | 57.53 |
Total Current Assets | 1,251 | 1,443 | 1,468 | 1,318 | 1,619 | 1,835 |
Net Property, Plant & Equipment | 340.59 | 441.27 | 359.11 | 470.85 | 401.2 | 235.03 |
Goodwill | 63.68 | 63.68 | 63.68 | 63.68 | 63.68 | 63.68 |
Long-Term Investments | 544.93 | 603.6 | 637.29 | 728.72 | 756.73 | 371.11 |
Other Long-Term Assets | 294.21 | 292.58 | 420.03 | 361.15 | 231.11 | 111.66 |
Total Assets | 2,494 | 2,844 | 2,948 | 2,942 | 3,071 | 2,616 |
Accounts Payable | 39.06 | 29.62 | 38.19 | 33.77 | 32.67 | 24.26 |
Accrued Expenses | 220.2 | 250.64 | 270.57 | 252.09 | 212.77 | 259.97 |
Other Current Liabilities | 102.66 | 125.38 | 95.01 | 108.42 | 78.92 | 53.37 |
Total Current Liabilities | 361.93 | 405.64 | 403.77 | 394.28 | 324.36 | 337.59 |
Long-Term Leases | 165.93 | 173.04 | 190.82 | 189.94 | 190.17 | 51.27 |
Other Long-Term Liabilities | 122.62 | 104.42 | 108.9 | 94.22 | 68.53 | 16.76 |
Total Long-Term Liabilities | 288.55 | 277.46 | 299.72 | 284.17 | 258.7 | 68.03 |
Total Liabilities | 650.47 | 683.1 | 703.49 | 678.45 | 583.06 | 405.62 |
Common Stock | 0.25 | 0.26 | 0.28 | 0.3 | 0.32 | 0.32 |
Additional Paid-in Capital | 2,108 | 2,234 | 2,344 | 2,441 | 2,537 | 2,428 |
Accumulated Other Comprehensive Income | -2.01 | 3.48 | -1.35 | -3.75 | -14.52 | -0.76 |
Retained Earnings | -262.53 | -76.83 | -98.65 | -173.35 | -34.23 | -216.51 |
Shareholders' Equity | 1,844 | 2,161 | 2,244 | 2,264 | 2,488 | 2,211 |
Total Liabilities & Equity | 2,494 | 2,844 | 2,948 | 2,942 | 3,071 | 2,616 |
Total Debt | 165.93 | 173.04 | 190.82 | 189.94 | 190.17 | 51.27 |
Net Cash (Debt) | 673.46 | 886.05 | 920.45 | 805.36 | 1,118 | 1,416 |
Net Cash Growth | 10.18% | -3.74% | 14.29% | -27.98% | -21.01% | 22.32% |
Net Cash Per Share | 2.58 | 3.14 | 3.11 | 2.50 | 3.45 | 4.39 |
Book Value | 1,844 | 2,161 | 2,244 | 2,264 | 2,488 | 2,211 |
Book Value Per Share | 7.06 | 7.67 | 7.58 | 7.04 | 7.67 | 6.86 |
Tangible Book Value | 1,780 | 2,098 | 2,181 | 2,200 | 2,425 | 2,147 |
Tangible Book Value Per Share | 6.81 | 7.44 | 7.36 | 6.84 | 7.47 | 6.66 |